Medical cannabis research, clinical studies, and patient access developments.
New study shows CBD aids athletic recovery and reduces muscle soreness without boosting performance, offering targeted m…
Read more →Endovia pursues FDA veterinary approval for cannabinoid drugs targeting canine cancer and chronic pain, seeking mainstre…
Read more →New study shows cannabis improves symptoms for restrictive eating disorders like anorexia. Learn what this means for can…
Read more →New scientific study highlights medical cannabis potential in dentistry for treating orofacial pain and periodontal dise…
Read more →Newly released VA records raise questions about how Cannabis Use Disorder diagnoses impact veterans using medical cannab…
Read more →New scientific review highlights cannabis and CBD as therapeutic options for restless leg syndrome, signaling new opport…
Read more →New study shows high doses of THC produce psychedelic-like states similar to psilocybin, offering potential implications…
Read more →New federally funded study highlights high costs of medical cannabis for cancer patients, fueling calls for health insur…
Read more →OHSU study shows Oregon psilocybin program delivers sustained mental health benefits, signaling growth for regulated alt…
Read more →Alabama's second medical cannabis dispensary opens in Talladega, marking a slow but steady expansion of patient access a…
Read more →New study shows 91% of older adults find relief from pain and insomnia using medical cannabis, signaling new opportuniti…
Read more →Kentucky medical cannabis program reaches milestone as half of licensed dispensaries open and patient counts exceed 25,0…
Read more →Kentucky governor announces the state medical marijuana program is past the halfway point to full operation, with cultiv…
Read more →UGA study reveals a 7% drop in health-related work absences in medical cannabis states, offering new data for industry a…
Read more →Illinois adds two new conditions to its medical cannabis program, expanding the patient base for dispensaries and brands…
Read more →CDC proposes adding cannabis medical versus recreational use questions to the 2028 federal health survey, shifting publi…
Read more →Illinois adds sickle cell disease and PMOS to medical cannabis qualifying conditions, expanding the state's patient base…
Read more →AMA-published study shows Oregon psilocybin program improves mental health, but financial hurdles threaten the nation's …
Read more →Medical cannabis research is accelerating as legal access expands and scientific interest grows. Peer-reviewed studies are examining cannabis and cannabinoids for pain management, anxiety, PTSD, epilepsy, cancer symptom relief, and dozens of other conditions. Clinical trial results, FDA decisions on cannabis-derived pharmaceuticals, and state medical program expansions all shape the medical cannabis market and the patients who depend on it. For dispensaries with medical programs, staying current on research helps staff educate patients and positions the brand as a trusted healthcare resource.
State medical cannabis programs continue to evolve — adding qualifying conditions, adjusting possession limits, and transitioning to or from adult-use frameworks. Healthcare provider attitudes toward cannabis recommendations are also shifting, with more physicians willing to discuss cannabis as an adjunct therapy. Medical dispensaries face unique compliance requirements around patient data, labeling, and product testing that differ from adult-use retail operations.
This section covers the latest medical cannabis studies, state program updates, patient access developments, and pharmaceutical cannabis research. Cannabis Promotions provides context on what each development means for medical dispensaries and the patients they serve.